A portable partition for use in an automobile having a seat with a seat bench and a seat backrest.
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7282221 | Antiviral product, use and formulation thereof An antiviral product is comprised of at least three dosages forms, each of which has a different release profile, with the Cmax for the antiviral product being reached in less than about twelve hours. In one embodiment, there is an immediate release dosag... | 10/16/2007 |
| 7115624 | Method of inhibiting protein tyrosine phosphatase 1B and/or T-cell protein tyrosine phosphatase 4 and/or other PTPases with an Asp residue at position 48 The present invention provides a method of inhibiting a member of a family of Protein Tyrosine Phosphatases (PTPases, PTPs) such as PTP1B, TC-PTP, CD45, SHP-1, SHP-2, PTPα, PTPε, PTPμ, PTPδ, PTPσ, PTPζ, PTPβ, PTPD1, PTPD2, PTPH1, PTP-MEG1, PTP-LAR, and HePTP ... | 10/03/2006 |
| 7022691 | Inhibitors of serine and metallo-β-lactamases Compounds of formula (I): wherein R1, R2, R3, R4 and n have any of the values defined in the specification, and their pharmaceutically acceptable salts, are useful for inhibiting simulta... | 04/04/2006 |
| 6916801 | 7-Alkylidene-3-substituted-3-cephem-4-carboxylates as β-lactamase inhibitors The invention provides compounds of formula (I): wherein: R1-R4 and A have any of the values defined in the specification, and their pharmaceutically acceptable salts, are useful for inhibiting β... | 07/12/2005 |
| 6906054 | Compositions for inhibiting beta-lactamase The invention provides pharmaceutical compositions comprising compounds of formula I and IV: wherein R1-R11 and A have any of the values defined in the specification, and ... | 06/14/2005 |
| 6689775 | Uses of thioredoxin The present invention relates to the use of thioredoxin as, inter alia, a cell growth stimulator, as well as a screen for agents that are useful in reducing or preventing thioredoxin-associated apoptosis inhibition and agents that are useful in inhibiting... | 02/10/2004 |
| 6531465 | Antibacterial cephalosporins A compound of formula ##STR1## wherein Ac, R1 and R2 have various meanings, a process for a preparation thereof and its use as a pharmaceutical, i.e. as antibacterial agent.... | 03/11/2003 |
| 6486149 | Composition comprising a crystallographically stable, amorphous cephalosporin and processes for the preparation thereof Processes are provided for the preparation of orally administrable, yellow and powdery compositions essentially consisting of particles composed of a homogeneous mixture of an amorphous Cefditoren pivoxil substance with a water soluble high-molecular addi... | 11/26/2002 |
| 6369049 | Treatment of mastitis The invention provides new fluorinated cephalosporin antibiotics of Formula I ##STR1## wherein Ra, Rb, Rc, Rd and Re, independently, are H, F or a C1 -C6 alkyl-(Z)n --... | 04/09/2002 |
| 6342493 | Crystallographically stable amorphous cephalosporin compositions and process for producing the same Processes are provided for the preparation of orally administrable, yellow and powdery compositions essentially consisting of particles composed of a homogeneous mixture of an amorphous Cefditoren pivoxil substance with a water soluble high-molecular addi... | 01/29/2002 |
| 6303592 | 7-alkylidene cephalosporanic acid derivatives and methods of using the same Derivatives of 7-alkylidene cephalosporanic acid sulfone and the pharmaceutically active salts thereof are found to be potent inhibitors of ଲ-lactamase enzymes.... | 10/16/2001 |
| 6262044 | Modulators of protein tyrosine phosphatases (PTPASES) The present invention provides novel compounds, novel compositions, methods of their use, and methods of their manufacture, where such compounds are pharmacologically useful inhibitors of Protein Tyrosine Phosphatases (PTPase's) such as PTP1B, CD45, SHP-1... | 07/17/2001 |
| 6133254 | Use of aspirochlorine or derivatives thereof as immunosuppressive agents Use of a compound of formula (I) wherein R represents hydrogen or chlorine, for preparing an immunosuppressive medicament.... | 10/17/2000 |
| 6066630 | Cephalosporin antibiotics The present invention includes novel compounds of formula ##STR1## where R99 is selected from the group consisting of sulfur, SO, SO2, NH, N-alkyl, oxygen, C.dbd.C (cis or trans), and C.tbd.C, and R12 is ##STR2##... | 05/23/2000 |
| 5994340 | Azetidinone derivatives as ଲ-lactamase inhibitors New 2-oxo-1-azetidine sulfonic acid derivatives with an aminoalkyl substituted "anti" (E-isomer) oxyimino group in the acylamino substituent at the 3 position of the monobactam ring. These compounds are potent inhibitors of bacterial ଲ-lactamases. T... | 11/30/1999 |
| 5776718 | Reversible protease inhibitors The invention relates to novel reversible protease inhibitors. The inhibitors are specific to cysteine proteases.... | 07/07/1998 |
| 5756493 | Cephalosporin antibiotics The present invention includes novel (7R)-7-(acylamino)-3-(arylthio)-3-cephem-4-carboxylic acids or their pharmacologically acceptable salts which exhibit antibiotic activity against a wide spectrum of organisms including organisms which are resistan... | 05/26/1998 |
| 5726170 | Clavulanic acid salts The salts are prepared by reacting a benzhydrylamine of the formula I (or a salt thereof) with clavulanic acid (or a salt thereof) in solvent, and isolating the resulting salt. In formula I, each of R1 and R2 is hydrogen (preferred) ... | 03/10/1998 |
| 5698547 | Cephalosporin antibiotics The present invention includes novel (7R)-7-(acylamino)-3-(arylthio)-3-cephem-4-carboxylic acids or their pharmacologically acceptable salts which exhibit antibiotic activity against a wide spectrum of organisms including organisms which are resistan... | 12/16/1997 |
| 5681563 | 7-vinylidene cephalosporins and methods of using the same Cephalosporins with an exocyclic allene in the 7-position and their pharmaceutically active salts are potent inhibitors of ଲ-lactamases and are therefore useful in the treatment of penicillin resistant infections.... | 10/28/1997 |
| 5629306 | 7-alkylidene cephalosporanic acid derivatives and methods of using the same Derivatives of 7-alkylidene cephalosporanic acid sulfone and the pharmaceutically active salts thereof are found to be potent inhibitors of ଲ-lactamase enzymes.... | 05/13/1997 |
| 5597817 | 7-vinylidene cephalosporins and methods of using the same Cephalosporins with an exocyclic allene in the 7-position and their pharmaceutically active salts are potent inhibitors of ଲ-lactamases and are therefore useful in the treatment of penicillin resistant infections.... | 01/28/1997 |
| 5593986 | Cephalosporin antibiotics The present invention includes novel (7R)-7-(acylamino)-3-(arylthio)-3-cephem-4-carboxylic acids or their pharmacologically acceptable salts which exhibit antibiotic activity against a wide spectrum of organisms including organisms which are resistan... | 01/14/1997 |
| 5585372 | Tricyclic cefem sulphones The present invention provides compounds of formula (I) and pharmaceutically or veterinarily salts thereof; ##STR1## wherein R1 is hydrogen or halogen or an organic group; R2 is hydrogen or an optionally substituted C1 | 12/17/1996 |
| 5580865 | 2,2-disubstituted cephem sulphones The present invention provides cephalosporin sulphones or formula (I), and pharmaceutically or veterinarily acceptable salts thereof; ##STR1## wherein n is zero, one or two; R1 is hydrogen, halogen or an optionally substituted C1 | 12/03/1996 |
| 5492925 | Thienyl-and furylpyrrole insecticidal and acaricidal agents There are provided thienyl- and furylpyrrole compounds of formula I ##STR1## and their use for the control of insects and acarina. Further provided are compositions and methods comprising those compounds for the protection of plants from attack by in... | 02/20/1996 |
| 5409917 | Topical treatment of acne with cephalosporins A method and composition for topically treating acne and acneiform dermal disorders includes applying an amount of a cephalosporin antibiotic effective to treat the acne and acneiform dermal disorders. The antibiotic is blended with a carrier suitable for... | 04/25/1995 |
| 5312813 | Biofilm reduction method A method of killing microorganisms which form a biofilm on a tissue or implant surfaces in a patient, and which are refractory to a biocide at a dose which is effective to kill the microorganism in planktonic form. The effect of the biocide is potentiated... | 05/17/1994 |
| 4994512 | Poly-methine compounds, condensation polymer having a poly-methine compound admixed therein and shaped articles produced therefrom Disclosed are poly-methine compounds having the formula: ##STR1## wherein R1 is an unsubstituted or substituted alkoxycarbonyl, cycloalkoxycarbonyl or aryloxycarbonyl radical; an unsubstituted or substituted carbamoyl radical; or an unsubs... | 02/19/1991 |
| 4931438 | Fungicides This invention relates to derivatives of acrylic acid useful as fungicides, to processes for preparing them, to fungicidal compositions containing them, and to methods of using them to combat fungi, especially fungal infections in plants.... | 06/05/1990 |
| 4760060 | 3-heteroaralkylthio carbacephem compounds and antibacterial pharmaceutical composition Carbacephem and cephem compounds represented by the formula: ##STR1## [Wherein X is S or CH2 ; n is an integer of 1 to 5; R1 is an unsubstituted or substituted heterocyclic group (where the heterocyclic group is a 5- or 6-member... | 07/26/1988 |
| 4749694 | Novel lysine esters used as absorption Novel lysine esters used as absorption enhancing agents for gastrointestinally and rectally administered drugs. Also provided are processes for preparation of said lysine ester compounds as well as pharmaceutical formulations and methods for their use as ... | 06/07/1988 |
| 4731360 | Acylcarnitines as absorption-enhancing agents for drug delivery through mucous membranes of the nasal, buccal, sublingual and vaginal compartments Acylcarnitine used as a nasal, buccal, sublingual and vaginal drug absorption enhancing vehicle for poorly absorbed drugs.... | 03/15/1988 |
| 4729989 | Enhancement of absorption of drugs from gastrointestinal tract using choline ester salts Choline ester salts are used as drug absorption enhancing agents for orally and rectally administered drugs.... | 03/08/1988 |
| 4692441 | Chorine esters as absorption-enhancing agents for drug delivery through mucous membranes of the nasal, buccal, sublingual and vaginal cavities Choline esters are used as drug absorption enhancing agents for drugs which are poorly absorbed from the nasal, oral, and vaginal cavities.... | 09/08/1987 |
| 4487768 | Cephem compounds The invention relates to novel compounds of high antimicrobial activity of the formula: ##STR1## wherein R1 is amino or protected amino, R2 is carboxy(lower)alkyl or protected carboxy(lower)alkyl, and R3 is carboxy or prot... | 12/11/1984 |
| 4479947 | Oral absorption enhancement of carboxylic acid pharmaceuticals using (5-alkyl-2-oxo-1,3-dioxolen-4-yl)methyl ester group The (5-R-2-oxo-1,3-dioxolen-4-yl)methyl moiety: ##STR1## wherein R is loweralkyl of 1-6 carbon atoms, especially methyl or t-butyl; when utilized as an ester on a pharmaceutical having a carboxylic acid functionality, enhances oral absorption of the ... | 10/30/1984 |
| 4477447 | 7-Acylaminocephalosporanic acid derivatives This invention relates to novel 7-acylaminocephalosporanic acid derivatives of high antimicrobial activity, to processes for their preparation, and to pharmaceutical compositions comprising said derivatives, said derivatives being of the formula: ##S... | 10/16/1984 |
| 4425337 | Adjuvants for rectal delivery of drug A method and drug form enhancing the rate of absorption of a rectally administered drug from the rectal compartment into the blood stream of a warm blooded animal. The method includes the steps of preparing a drug form capable of being rectally administer... | 01/10/1984 |
| 4406896 | Adjuvants for rectal delivery of drug substances A method and drug form for enhancing the rate of absorption of a rectally administered drug from the rectal compartment into the blood stream of a warm blooded animal. The method includes the steps of preparing a ଲ-lactam drug form capable of being ... | 09/27/1983 |